JP2019515040A5 - - Google Patents

Download PDF

Info

Publication number
JP2019515040A5
JP2019515040A5 JP2019510569A JP2019510569A JP2019515040A5 JP 2019515040 A5 JP2019515040 A5 JP 2019515040A5 JP 2019510569 A JP2019510569 A JP 2019510569A JP 2019510569 A JP2019510569 A JP 2019510569A JP 2019515040 A5 JP2019515040 A5 JP 2019515040A5
Authority
JP
Japan
Prior art keywords
ophthalmic composition
composition according
ophthalmic
eye
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019510569A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019515040A (ja
JP6941157B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/031211 external-priority patent/WO2017192944A1/en
Publication of JP2019515040A publication Critical patent/JP2019515040A/ja
Publication of JP2019515040A5 publication Critical patent/JP2019515040A5/ja
Application granted granted Critical
Publication of JP6941157B2 publication Critical patent/JP6941157B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019510569A 2016-05-06 2017-05-05 眼科用組成物 Active JP6941157B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662332789P 2016-05-06 2016-05-06
US62/332,789 2016-05-06
US201662337571P 2016-05-17 2016-05-17
US62/337,571 2016-05-17
PCT/US2017/031211 WO2017192944A1 (en) 2016-05-06 2017-05-05 Ophthalmic compositions

Publications (3)

Publication Number Publication Date
JP2019515040A JP2019515040A (ja) 2019-06-06
JP2019515040A5 true JP2019515040A5 (enExample) 2020-06-11
JP6941157B2 JP6941157B2 (ja) 2021-09-29

Family

ID=58709627

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019510569A Active JP6941157B2 (ja) 2016-05-06 2017-05-05 眼科用組成物

Country Status (10)

Country Link
US (2) US10610499B2 (enExample)
EP (1) EP3452093B1 (enExample)
JP (1) JP6941157B2 (enExample)
CN (1) CN109715215A (enExample)
AU (1) AU2017261303B9 (enExample)
BR (1) BR122024001664A2 (enExample)
CA (1) CA3022983C (enExample)
DK (1) DK3452093T3 (enExample)
TW (1) TWI738774B (enExample)
WO (1) WO2017192944A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3022983C (en) 2016-05-06 2024-05-07 SaCSh Corp. Ophthalmic compositions comprising chlorhexidine and an anti-inflammatory agent
KR102340804B1 (ko) * 2019-07-22 2021-12-17 주식회사 휴온스메디케어 클로르헥시딘 또는 이의 유도체를 포함하는 항균 지속성이 개선된 수용성 소독용 조성물 및 이를 포함하는 섬유형 소독제
MX2022006523A (es) * 2019-12-03 2022-07-01 Ntc S R L Composicion que comprende budesonida para uso oftalmico.
US12357594B1 (en) 2021-06-30 2025-07-15 Sage Products, Llc Antimicrobial solution for pre-operative preparation
US11951087B2 (en) * 2021-07-27 2024-04-09 Lanny Leo Johnson Eye wash compositions and methods
WO2025176750A1 (en) 2024-02-23 2025-08-28 Heinrich-Heine-Universität Düsseldorf Dual targeting in a new class of active ingredients
CN119792261B (zh) * 2025-03-14 2025-07-11 华中科技大学同济医学院附属同济医院 治疗泌尿系感染的抗菌剂及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO59572A2 (enExample) 1972-01-29 1976-03-15
JP3781792B2 (ja) * 1993-12-27 2006-05-31 千寿製薬株式会社 ジフルプレドナート含有点眼用懸濁液剤
US5556848A (en) * 1993-12-27 1996-09-17 Senju Pharmaceutical Co., Ltd. Ophthalmic suspension containing diflupredonate
ATE215821T1 (de) * 1995-01-20 2002-04-15 Wakamoto Pharma Co Ltd Entzündungshemmende augentropfen
GB9616208D0 (en) * 1996-08-01 1996-09-11 Smithkline Beecham Plc Novel Compounds
US6218428B1 (en) 2000-04-28 2001-04-17 Emil Chynn Ophthalmic composition
US6872705B2 (en) 2001-07-13 2005-03-29 Allergan, Inc. Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
US20050234018A1 (en) * 2004-04-15 2005-10-20 Allergan, Inc. Drug delivery to the back of the eye
DE102005046769A1 (de) * 2005-09-29 2007-04-05 Berlin-Chemie Ag Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus)
WO2009006130A2 (en) 2007-06-28 2009-01-08 Bausch & Lomb Incorporated Salt free hyaluronate ophthalmic solution
WO2010107525A1 (en) * 2009-03-17 2010-09-23 Aciex Therapeutics, Inc. Ophthalmic formulations of ketotifen and methods of use
US9017725B2 (en) 2009-06-09 2015-04-28 Aurinia Pharmaceuticals Inc. Topical drug delivery systems for ophthalmic use
US20130165419A1 (en) 2011-12-21 2013-06-27 Insite Vision Incorporated Combination anti-inflammatory ophthalmic compositions
CN102973925A (zh) * 2012-11-27 2013-03-20 顾月燕 一种促进伤口愈合的组合物的制备方法
CN105979940A (zh) * 2013-12-12 2016-09-28 创新技术股份有限公司 控制感染的材料和方法
CA3022983C (en) 2016-05-06 2024-05-07 SaCSh Corp. Ophthalmic compositions comprising chlorhexidine and an anti-inflammatory agent

Similar Documents

Publication Publication Date Title
JP2019515040A5 (enExample)
JP6527341B2 (ja) ポビドンヨード、眼科用組成物のための新規代替保存剤
JP2014516954A5 (enExample)
CA2784492C (en) Non-irritating ophthalmic povidone-iodine compositions
JP2020196718A5 (enExample)
JP2015007136A5 (enExample)
JP2019526629A (ja) 眼科用組成物
WO2016171152A1 (ja) 角膜障害の治療剤、改善剤または予防剤
JP4849288B2 (ja) 点眼剤及び涙液膜の安定化剤
JP2012006962A (ja) 眼科用組成物
AU2017235979B2 (en) Non-irritating ophthalmic povidone-iodine compositions
AU2019268200B2 (en) Povidone iodine, a novel alternative preservative for ophthalmic compositions
HK1155041A (en) Povidone iodine, a novel alternative preservative for ophthalmic compositions
HK1155041B (en) Povidone iodine, a novel alternative preservative for ophthalmic compositions
JP2005187458A (ja) シロミラストまたはその塩を有効成分とする掻痒治療剤
WO2007099431A2 (en) An aqueous liquid pharmaceutical compositions of gatifloxacin